Magnetic dextran-spermine nanoparticles as pH-sensitive carriers for antibiotic delivery
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems · Drug Solubulity and Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (61)
Show source-provided references
1. Zhu X et al (2014) Nanomedicine in the management of microbial infection–overview and perspectives. Nano Today 9(4):478–49810.1016/j.nantod.2014.06.003 ↗
2. Craparo EF et al (2011) Nanoparticulate systems for drug delivery and targeting to the central nervous system. CNS neurosci Ther 17(6):670–67710.1111/j.1755-5949.2010.00199.x ↗
3. Ghaeini-Hesaroeiye S, Boddohi S, Vasheghani-Farahani E (2020) Dual responsive chondroitin sulfate based nanogel for antimicrobial peptide delivery. Int J Bio Macromol 143:297–30410.1016/j.ijbiomac.2019.12.026 ↗
4. Nasrollahzadeh M et al (2022) Drug in adhesive transdermal patch containing antibiotic-loaded solid lipid nanoparticles. J Biosci Bioeng 134(5):471–47610.1016/j.jbiosc.2022.08.003 ↗
5. Shao Q et al (2022) Protein corona mediated liposomal drug delivery for bacterial infection management. Asian J Pharm Sci 17(6):855–86610.1016/j.ajps.2022.10.003 ↗
6. Xu H et al (2015) Amphiphilic poly (amino acid) based micelles applied to drug delivery: the in vitro and in vivo challenges and the corresponding potential strategies. J Control Release 199:84–9710.1016/j.jconrel.2014.12.012 ↗
7. Shaki H et al (2018) Self-assembled amphiphilic-dextran nanomicelles for delivery of rapamycin. J Drug Deliv Sci Technol 44:333–34110.1016/j.jddst.2018.01.010 ↗
8. Jafarzadeh-Holagh S et al (2018) Self-assembled and pH-sensitive mixed micelles as an intracellular doxorubicin delivery system. J Colloid Inter Sci 523:179–19010.1016/j.jcis.2018.02.076 ↗
9. Wang Y, Wang PG (2013) Polysaccharide-based systems in drug and gene delivery. Adv Drug Deliv Rev 65(9):1121–112210.1016/j.addr.2013.07.001 ↗
10. Prasher P et al (2022) Advances and applications of dextran-based nanomaterials targeting inflammatory respiratory diseases. J Drug Deliv Sci Tech 74:10359810.1016/j.jddst.2022.103598 ↗
11. Yang J et al (2012) The biocompatibility of fatty acid modified dextran-agmatine bioconjugate gene delivery vector. Biomater 33(2):604–61310.1016/j.biomaterials.2011.09.067 ↗
12. Yao X et al (2014) Intercellular pH-responsive histidine modified dextran-g-cholesterol micelle for anticancer drug delivery. Colloids Surf B: Biointerfaces 121:36–4310.1016/j.colsurfb.2014.05.032 ↗
13. Tiryaki E et al (2020) Novel organic/inorganic hybrid nanoparticles as enzyme-triggered drug delivery systems: dextran and dextran aldehyde coated silica aerogels. J Drug Deliv Sci Tech 56:10151710.1016/j.jddst.2020.101517 ↗
14. Abeylath SC, Amiji MM (2011) ‘Click’synthesis of dextran macrostructures for combinatorial-designed self-assembled nanoparticles encapsulating diverse anticancer therapeutics. Bioorg Med Chem 19(21):6167–617310.1016/j.bmc.2011.09.024 ↗
15. Thomas JJ, Rekha M, Sharma CP (2010) Dextran–glycidyltrimethylammonium chloride conjugate/DNA nanoplex: a potential non-viral and haemocompatible gene delivery system. Int J Pharm 389(1–2):195–20610.1016/j.ijpharm.2010.01.011 ↗
16. Shaki H et al (2021) A self assembled dextran-stearic acid-spermine nanocarrier for delivery of rapamycin as a hydrophobic drug. J Drug Deliv Sci Tech 66:10276810.1016/j.jddst.2021.102768 ↗
17. Tarvirdipour S et al (2016) Functionalized magnetic dextran-spermine nanocarriers for targeted delivery of doxorubicin to breast cancer cells. Int J Pharm 501(1–2):331–34110.1016/j.ijpharm.2016.02.012 ↗
18. Ghadiri M et al (2017) Transferrin-conjugated magnetic dextran-spermine nanoparticles for targeted drug transport across blood-brain barrier. J Biomed Mater Res Part A 105(10):2851–286410.1002/jbm.a.36145 ↗
19. Du Y-Z et al (2010) Synthesis and antitumor activity of stearate-g-dextran micelles for intracellular doxorubicin delivery. ACS Nano 4(11):6894–690210.1021/nn100927t ↗
20. Mohammad-Taheri M, Vasheghani-Farahani E, Hosseinkhani H, Shojaosadati SA, Soleimani M (2012) Fabrication and characterization of a new MRI contrast agent based on a magnetic dextran–spermine nanoparticle system. Iranian Polym J 21(4):239–25110.1007/s13726-012-0027-0 ↗
21. Ghadiri M et al (2017) Transferrin-conjugated magnetic dextran-spermine nanoparticles for targeted drug transport across blood-brain barrier. J Biomed Mater Res A 105(10):2851–286410.1002/jbm.a.36145 ↗
22. Jafarzadeh-Holagh S et al (2018) Self-assembled and pH-sensitive mixed micelles as an intracellular doxorubicin delivery system. J Colloid Interface Sci 523:179–19010.1016/j.jcis.2018.02.076 ↗
23. Lê MQ et al (2019) Protein delivery by porous cationic maltodextrin-based nanoparticles into nasal mucosal cells: comparison with cationic or anionic nanoparticles. Int J Pharm: X 1:100001
24. Wu X et al (2018) Inhibition of intrinsic coagulation improves safety and tumor-targeted drug delivery of cationic solid lipid nanoparticles. Biomaterials 156:77–8710.1016/j.biomaterials.2017.11.040 ↗
25. Ghadiri M et al (2017) In-vitro assessment of magnetic dextran-spermine nanoparticles for capecitabine delivery to cancerous cells. Iranian J Pharm Res: IJPR 16(4):1320
26. Azzam T et al (2002) Cationic polysaccharides for gene delivery. Macromolecules 35(27):9947–995310.1021/ma0209592 ↗
27. Zhao T et al (2015) Self-assembly and cytotoxicity study of PEG-modified ursolic acid liposomes. Mater Sci Eng C Mater Biol Appl 53:196–20310.1016/j.msec.2015.04.022 ↗
28. Siepmann J, Peppas NA (2012) Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv drug Deliv Rev 64:163–17410.1016/j.addr.2012.09.028 ↗
29. Ramakrishna S et al (2012) Design and evaluation of drug release kinetics of meloxicam sustained release matrix tablets. Int J Curr Pharm Res 4(1):90–99
30. Mohammad-Taheri M et al (2012) Fabrication and characterization of a new MRI contrast agent based on a magnetic dextran–spermine nanoparticle system. Iranian Polym J 21(4):239–25110.1007/s13726-012-0027-0 ↗
31. Kataoka K, Harada A, Nagasaki Y (2001) Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 47(1):113–13110.1016/S0169-409X(00)00124-1 ↗
32. Gothwal A, Khan I, Gupta U (2016) Polymeric micelles: recent advancements in the delivery of anticancer drugs. Pharm Res 33(1):18–3910.1007/s11095-015-1784-1 ↗
33. Raveendran R, Bhuvaneshwar GS, Sharma CP (2016) Hemocompatible curcumin–dextran micelles as pH sensitive pro-drugs for enhanced therapeutic efficacy in cancer cells. Carbohyd Polym 137:497–50710.1016/j.carbpol.2015.11.017 ↗
34. Kazemi-Ashtiyani M, Hajipour-Verdom B, Satari M, Abdolmaleki P, Hosseinkhani S, Shaki H (2022) Estimating the two graph dextran–stearic acid–spermine polymers based on iron oxide nanoparticles as carrier for gene delivery. Biopolymers 113(7):2349110.1002/bip.23491 ↗
35. Danaei M et al (2018) Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics 10(2):5710.3390/pharmaceutics10020057 ↗
36. Masarudin MJ et al (2015) Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [(14)C]-doxorubicin. Nanotechnol Sci Appl 8:67–8010.2147/NSA.S91785 ↗
37. Ternullo S et al (2018) Deformable liposomes for skin therapy with human epidermal growth factor: The effect of liposomal surface charge. Eur J Pharm Sci 125:163–17110.1016/j.ejps.2018.10.005 ↗
38. Liu X, Zhou H, Yu W (2013) Effect of surface charge of amphiphlic chitosan nanocarriers on drug release behavior. J Control Release 172(1):e7810.1016/j.jconrel.2013.08.160 ↗
39. Soheyla Honary FZ (2013) Effect of zeta potential on the properties of nano-drug delivery systems - a review (part 1). Tropical J Pharm Res 12(2):255–264
40. Pardeshi SR et al (2023) Novel crosslinked nanoparticles of chitosan oligosaccharide and dextran sulfate for ocular administration of dorzolamide against glaucoma. J Drug Deliv Sci Tech 86:10471910.1016/j.jddst.2023.104719 ↗
41. Haddad N et al (2022) The blood-brain barrier and pharmacokinetic/pharmacodynamic optimization of antibiotics for the treatment of central nervous system infections in adults. Antibiotics (Basel) 11(12):1843. https://doi.org/10.3390/antibiotics1112184310.3390/antibiotics11121843 ↗
42. Ghadiri M et al (2017) In-vitro assessment of magnetic dextran-spermine nanoparticles for capecitabine delivery to cancerous cells. Iran J Pharm Res 16(4):1320–1334
43. Rani NNIM et al (2022) Surface-engineered liposomes for dual-drug delivery targeting strategy against methicillin-resistant Staphylococcus aureus (MRSA). Asian J Pharm Sci 17(1):102–11910.1016/j.ajps.2021.11.004 ↗
44. Avazzadeh R et al (2017) Synthesis and application of magnetite dextran-spermine nanoparticles in breast cancer hyperthermia. Prog Biomater 6:75–8410.1007/s40204-017-0068-8 ↗
45. Xu J et al (2015) Preparation and evaluation of vancomycin-loaded N-trimethyl chitosan nanoparticles. Polymers 7(9):1850–187010.3390/polym7091488 ↗
46. Mok H, Zhang M (2013) Superparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeutics. Expert Opin Drug Deliv 10(1):73–8710.1517/17425247.2013.747507 ↗
47. Eliyahu H et al (2006) Relationships between chemical composition, physical properties and transfection efficiency of polysaccharide-spermine conjugates. Biomaterials 27(8):1646–165510.1016/j.biomaterials.2005.09.005 ↗
48. Siepmann J, Peppas NA (2001) Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev 48(2):139–15710.1016/S0169-409X(01)00112-0 ↗
49. Tavakol M, Vasheghani-Farahani E, Hashemi-Najafabadi S (2013) The effect of polymer and CaCl 2 concentrations on the sulfasalazine release from alginate-N O-carboxymethyl chitosan beads. Prog in Biomater 2:1–810.1186/2194-0517-2-10 ↗
50. Vollmerhaus PJ, Breukink E, Heck AJ (2003) Getting closer to the real bacterial cell wall target: biomolecular interactions of water-soluble lipid II with glycopeptide antibiotics. Chemistry 9(7):1556–156510.1002/chem.200390179 ↗
51. Zazo H, Colino CI, Lanao JM (2016) Current applications of nanoparticles in infectious diseases. J Control Release 224:86–10210.1016/j.jconrel.2016.01.008 ↗
52. Baran A et al (2022) Investigation of antimicrobial and cytotoxic properties and specification of silver nanoparticles (AgNPs) derived from Cicer arietinum L. green leaf extract. Front Bioeng Biotech 10:1–11. https://doi.org/10.3389/fbioe.2022.85513610.3389/fbioe.2022.855136 ↗
53. Baran A et al (2021) Ecofriendly synthesis of silver nanoparticles using ananas comosus fruit peels: anticancer and antimicrobial activities. Bioinorganic Chem App 2021:2058149
54. Kiem S, Schentag JJ (2006) Relationship of minimal inhibitory concentration and bactericidal activity to efficacy of antibiotics for treatment of ventilator-associated pneumonia. Semin Respir Crit Care Med 27(1):51–6710.1055/s-2006-933674 ↗
55. Mouton JW, Vinks AA (2005) Relationship Between minimum inhibitory concentration and stationary concentration revisited. Clin Pharmacokinetics 44(7):767–76810.2165/00003088-200544070-00007 ↗
56. Kalhapure RS et al (2015) Nanoengineered drug delivery systems for enhancing antibiotic therapy. J Pharm Sci 104(3):872–90510.1002/jps.24298 ↗
57. Stebbins ND, Ouimet MA, Uhrich KE (2014) Antibiotic-containing polymers for localized, sustained drug delivery. Adv Drug Deliv Rev 78:77–8710.1016/j.addr.2014.04.006 ↗
58. Ferraro MJ (2001) Should we reevaluate antibiotic breakpoints? Clin Infect Dis 33(Suppl 3):S227–S22910.1086/321852 ↗
59. Jorgensen JH (2004) Who defines resistance? The clinical and economic impact of antimicrobial susceptibility testing breakpoints. Semin Pediatr Infect Dis 15(2):105–10810.1053/j.spid.2004.01.014 ↗
60. Kumar, Vrinda S, Vinayan KP (2024) Comparative in vivo biodistribution and pharmacokinetic evaluation of phenytoin sodium loaded polymeric nanomicelles and marketed phenytoin sodium iv. J Nanoparticle Res 26(2):2410.1007/s11051-023-05911-2 ↗
61. Shariare MH et al (2024) Phospholipid-based nano drug delivery system of curcumin using MSP1D1 protein and poloxamer 407: a comparative study for targeted drug delivery to the brain. J Nanoparticle Res 26(1):1210.1007/s11051-023-05921-0 ↗